| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.009 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |